TransDigm Group Incorporated (NYSE: TDG) — A Private-Equity Compounder, Finally on the Cheaper Side of Its Own Block

Report date: 2026-06-14 · Price referenced: $1,255.67 (close 2026-06-12) · Market cap: ~$70.3B · Net debt: ~$29B (pro forma recent M&A) · EV: ~$99B Note: The analysis below makes no recommendation and sets no price target — it frames embedded expectations and scenarios only. The single exception is the Claude's Take block immediately below.

⚡ Claude’s Take

This block is the author’s own independent opinion and is general information only — not investment advice. The analysis (sections 1–15) that follows takes no position and carries no price target.

Verdict: HOLD / accumulate-on-weakness / NOT a short — leaning constructive. The rare case of a proven ~20%-per-share compounder trading at the bottom of its own quality cohort’s multiple range after a fundamentals-intact air-pocket. Accumulation zone ~$1,050–1,200 (≈16–18x forward EV/EBITDA-As-Defined / ~27–30x forward adjusted EPS); below ~$1,050 it becomes a genuine quality-on-sale, back-up-the-truck setup.

TransDigm is one of the most effective capital-compounding machines in the public market, and the thesis is unusually clean: own proprietary, sole-source aircraft components (~90% of sales proprietary, ~80% sole-source, ~55% high-margin aftermarket), raise prices above inflation every year on parts no one can economically re-qualify, harvest a 60% gross / 54% EBITDA margin, bolt on more of the same with debt, and strip the equity out through serial special dividends — a $9.6B payout in FY2025 alone. ROIC has climbed from ~10% (COVID trough) to ~17%, revenue from $4.8B to $8.8B in four years, and EBITDA margin from 40% to 54%. This is a genuinely great business with a financially-proven moat. What makes it interesting right now is the price. Unlike Howmet (which I flagged at the 95th percentile of its own valuation history, “priced for a cloudless sky”), TDG sits at the 64th percentile of its own ten-year range, is down ~23% from its $1,624 peak, trades at the lowest EV/EBITDA in its entire compounder cohort (~21x trailing / ~18x forward vs HEICO ~34x, Howmet ~42x, Curtiss-Wright ~34x) despite the highest margins, and offers a ~3.4% forward free-cash-flow yield (vs HWM’s ~1.3%). The de-rate came from a FY2025 commercial-aftermarket air-pocket — distributor destocking plus low Boeing/Airbus build rates — that the Q2-FY26 beat-and-raise (revenue +18%, aftermarket guide lifted to low-double-digits, 737 MAX rates climbing) suggests is already rolling off.

The framing is “quality compounder at a reasonable-for-once multiple,” not momentum and not a falling knife. The factor tape supports it: positive alpha (+0.05), low beta (~0.83), Quality and Low-Volatility loadings, and a cooled (not crashing) momentum signal — a strong long-run performer that has gone sideways for a year, exactly the setup where the multiple does the work on the way back. The reasons I stop at HOLD-leaning-constructive rather than an outright BUY are real and structural: ~5.7x net leverage into a possibly late-cycle backdrop (the equity is rate-sensitive and the $30B debt stack magnifies any aftermarket downturn), a recurring DoD/Congressional pricing-headline risk now that defense is >40% of revenue, the law-of-large-numbers question on an $8.8B base, and an absolute multiple (~32x earnings) that is reasonable for this business but not cheap. Conviction: medium-high. The single fact that would flip me to a full BUY: two more quarters confirming aftermarket has durably re-accelerated to low-double-digits with leverage trending toward the low-5s. The single fact that would flip me bearish: a binding legislative/DoD cost-data regime that caps sole-source pricing on the defense book, or a commercial-aftermarket relapse that exposes the leverage. Tag: “The PE fund you can buy at a public-market discount — for once, the discount is real.”

1. Executive Summary

TransDigm Group (NYSE: TDG) is a designer and producer of highly-engineered, largely proprietary aircraft components, run as a permanent private-equity vehicle inside a public listing. The model is explicit and unwavering: own businesses that make proprietary, sole-source parts with large, recurring, high-margin aftermarket demand; apply a disciplined value-based operating playbook (pricing, productivity, new-business development); acquire more of the same at prices that pencil to ~20% IRRs; run a deliberately leveraged balance sheet; and return capital to shareholders through episodic, debt-funded special dividends and opportunistic buybacks. The stated goal — repeated verbatim for two decades — is “private-equity-like returns with the liquidity of the public market.”

The financial record validates the model. FY2025 (ended September 30, 2025) revenue was $8,831M, +11.2% YoY, with 60.1% gross margin, EBITDA-As-Defined of $4,760M (53.9% margin), GAAP operating income of $4,189M, net income of $2,074M, and GAAP diluted EPS of $35.64. Over four years revenue grew from a COVID trough of $4,798M (FY2021) to $8,831M; EBITDA margin expanded from 40.5% to 53.9%; and ROIC rose from ~9.7% to ~16.9%. The business throws off cash with almost no capital intensity (capex <2% of sales), funding both the acquisition engine and the dividends. Roughly 90% of sales are proprietary, ~80% sole-source, and ~55% aftermarket — the structural signature of pricing power.

The moat is real and namable. In Greenwald’s taxonomy it is intangibles (sole-source design-win plus FAA qualification lock-in on platforms with multi-decade service lives) reinforced by switching costs (re-qualifying a flight-critical, low-dollar part is uneconomic) and a niche cost/scale edge. The moat is not asserted — it is visible in the financials: a 60% gross margin and documented above-inflation price increases on parts with no qualified alternative. The industry backdrop is favorable: commercial aero is mid-cycle on original-equipment build (737 MAX and A320neo ramping) but early in the higher-margin aftermarket cycle, and defense — now >40% of revenue — rides a funded global re-armament tailwind.

Capital allocation is the company’s defining competence — and its defining risk. TransDigm has compounded per-share value extraordinarily by combining accretive M&A with a leveraged-equity structure: it carries ~$30B of gross debt (net leverage ~5.7x, deliberately within a 5–7x target band), runs a negative book equity of −$9.7B (an output of serial special dividends, not distress), and has returned enormous sums — including ~$9.6B of special dividends in FY2025 alone ($75/share + $90/share). Management incentive compensation is genuinely returns-aware: options vest on per-share operating-performance growth (full vesting at 17.5%/yr, zero below 10%), and say-on-pay support recovered from 33.8% (2022) to 94.4% (2025). The blemishes are structural: episodic DoD-Inspector-General “excess profit” findings (refunds of $16.1M in 2019 and ~$21M in 2021), a 2017 short-seller broadside (“the Valeant of aerospace”), and essentially zero insider open-market buying.

The catch this time is not the price — it is the leverage and the politics. Unusually for a business of this quality, TDG is not expensively valued relative to its own history or its cohort. It trades at ~21x trailing / ~18x forward EV/EBITDA-As-Defined, ~36x trailing / ~32x forward earnings, ~8x sales, a ~3.4% forward FCF yield, and the 64th percentile of its own ten-year valuation range — the cheapest EV/EBITDA in the aerospace-compounder cohort (HEICO ~34x, Howmet ~42x, Curtiss-Wright ~34x) despite the highest margins. The market’s discount is for the 5.7x leverage, the recurring defense-pricing headline risk, and the maturity/large-numbers question — not for any deterioration in the franchise. This report takes no position; the body lays out the embedded expectations and the bear/base/bull scenarios so a reader can weigh whether the discount is adequate compensation for the leverage and the politics.

2. Business Overview

TransDigm makes mission-critical, highly-engineered components that go onto aircraft and stay there for the platform’s multi-decade life. Founded in 1993 and based in Cleveland, Ohio, it has grown — almost entirely by acquisition — into a ~$8.8B-revenue, ~$99B-enterprise-value franchise spanning ~50-plus decentralized operating units. The product catalog is deliberately mundane and irreplaceable: pumps, valves, actuators, ignition systems, specialized motors and generators, sensors, cockpit displays, latching and locking devices, connectors, seat belts and restraints, lavatory hardware, parachutes, and audio/antenna systems. Individually these are small-dollar parts; collectively they are the connective tissue of an airframe, and most are sole-sourced to a specific platform.

Three reporting segments (FY2025):

Power & Control is the higher-margin half (56.9% segment EBITDA-As-Defined margin), reflecting heavier proprietary/sole-source content; Airframe is nearly as large and almost as profitable (53.7%); Non-aviation is a small, lower-margin diversifier the company is happy to let stagnate. Segment EBITDA-As-Defined totaled $4,872M (55.2% of segment sales) before ~$112M of unallocated corporate cost, yielding the $4,760M company figure.

How it makes money — the razor-and-blade structure. TransDigm’s economics are defined less by what it sells than by how the revenue recurs. ~55% of net sales are aftermarket (the “blades”) — spare parts and repairs consumed over the decades an aircraft flies — and the vast majority of EBITDA derives from that aftermarket because aftermarket margins are dramatically higher than original-equipment (OE) margins. The ~45% OE business (the “razors”) is the channel by which TransDigm content gets designed onto a platform; once qualified, it generates a long, high-margin spares tail tied to the installed base. The end-market mix is roughly: commercial aftermarket (the crown jewel — recurring, high-margin), commercial OE (lower-margin, cyclical, build-rate-driven), defense (now >40% of total revenue across OE and aftermarket, funded and counter-cyclical to commercial), and a small non-aero remainder.

Recurring vs. non-recurring. The aftermarket book is economically recurring — it is a function of the installed fleet flying, not of new-aircraft orders — which is why TransDigm has historically been far less cyclical through downturns than the OE supply chain. The defense book adds a second, government-funded leg of recurring demand. Only the ~45% OE portion is genuinely cyclical, and even there the content, once qualified, is locked for the program’s life.

Verdict: A focused, decentralized, aftermarket-heavy components company whose center of gravity sits in the single best profit pool in aerospace — proprietary, sole-source parts with a long recurring spares tail. The revenue base is high-margin, increasingly defense-diversified, and structurally recurring. This is, by construction, a very good business.

3. Industry Dynamics

The commercial aerospace aftermarket is structurally one of the best profit pools in all of industrials, and it is durable rather than cyclical. The value chain runs airframers (Boeing, Airbus) → engine OEMs (GE Aerospace, Pratt & Whitney, Safran/CFM, Rolls-Royce) → component tier-1s (TransDigm, Howmet, HEICO) → raw materials. The defensible economics live in the content layers and, above all, in the aftermarket, where suppliers harvest decades of high-margin spare-parts demand from content qualified onto a platform at low or negative OE margin. A mission-critical $5,000 actuator is bought on availability and certification, not price — the demand is recurring and price-inelastic. TransDigm’s own ~54% EBITDA margin, with roughly two-thirds of EBITDA from aftermarket, is the financial fingerprint of sitting in exactly the right place.

Market size and the traffic driver. The global commercial MRO/aftermarket is roughly $139B in 2026 (Oliver Wyman), growing toward ~$165B by 2035 (~3.9% CAGR), with engine MRO the fastest-growing slice. The demand engine is utilization: IATA forecasts 2026 revenue-passenger-kilometers up ~4–5% and a record ~5.2B passengers. A growing, hard-flying global fleet drives shop visits and parts replacement regardless of new-build rates — the reason aftermarket-levered names are less cyclical than the OE chain.

The OE cyclical leg is mid-cycle and recovering. As of mid-2026, Boeing’s 737 MAX is ramping toward ~47/month (from 42, after the FAA-imposed 38 cap), and Airbus’s A320neo family runs ~50–55/month with a 75/month target slipping toward end-2027 (partly on Pratt engine constraints). For TransDigm this OE recovery matters less for its own (lower-margin) OE revenue than for the future aftermarket it seeds: every narrowbody delivered today is decades of spares tomorrow. The FY2025 weakness in commercial OE — low rates plus the 2024 Boeing strike plus distributor destocking — is precisely what is now reversing.

Defense is a funded, multi-decade tailwind. The FY2026 US base defense appropriation is ~$895B, with supplementals pushing outlays higher; NATO’s 2025 Hague summit committed members to 5%-of-GDP defense spending (3.5% core) by 2035. With defense now >40% of TransDigm revenue and growing double-digits, this is a structural support — though, as discussed below, it is also the source of the company’s pricing-politics risk.

Regulatory structure is, on net, a barrier that helps incumbents. The FAA certification/qualification regime makes a second source for a flight-critical part uneconomic to introduce — years of cost, testing, and safety/regulatory risk for a part that is a tiny share of aircraft cost. That same regime, applied on the defense side through DoD procurement, is where the political friction arises (the buyer is a single sophisticated counterparty with audit and subpoena power).

Capital cycle (Marathon lens). Supply discipline on the operating side is high — capital cannot simply flood in and compete away an installed-base spares franchise, because the installed base is locked by certification. Where capital is flowing is M&A: TransDigm, HEICO, and private-equity roll-ups bid up scarce proprietary/aftermarket assets, and prices are full (the ~$2.2B Jet Parts/Victor Sierra deal at ~7.9x revenue, and a topping war over tiny Servotronics, are evidence of a hot acquisition market). So the classic high-return/disciplined-supply setup holds on operations, but the capital-deployment side is late-cycle — assets are expensive and TransDigm is deploying debt into them at full prices.

Verdict: structurally good industry — among the best in industrials. Recurring, installed-base-driven, FAA-barrier-protected, price-inelastic aftermarket demand, plus a funded defense tailwind. The honest caveats: the quality is no secret (acquisition prices reflect it), and the OE leg is mid-to-late cycle. But the underlying profit pool is genuinely excellent and durable.

4. Competitive Position

The moat is real, financially-proven, and best described as intangibles + switching costs with a niche cost/scale edge. TransDigm wins a sole-source design position on a specific aircraft platform with a proprietary, highly-engineered component, then rides that platform’s 30-year-plus production-and-service life. ~90% of FY2025 net sales were proprietary products, and the majority are sole-sourced — meaning there is, by design, no qualified alternative the customer can buy instead.

The switching cost is regulatory-physical, not contractual. To replace a TransDigm sole-source part, a customer would have to fund and qualify a new supplier under the FAA regime — years of engineering, testing, certification, and safety/liability risk — to save a few hundred or few thousand dollars on a part that is mission-critical to dispatching a multi-hundred-million-dollar aircraft. No rational airline or MRO does this. That asymmetry is the engine of value-based pricing: annual price increases that run, by the company’s own description, “in excess of” inflation and input-cost pass-through.

The moat passes the only test that matters — it shows up in the financials. A 60.1% gross margin, a 53.9% EBITDA-As-Defined margin, and ~50%+ incremental operating margins on small-dollar mechanical parts are economics no price-taker could earn. A commodity component supplier earns 15–25% gross margins; TransDigm earns 60% because, for ~80% of its catalog, the customer has nowhere else to go. If the pricing power evaporated, those margins would collapse toward the industrial mean — and they have instead expanded for a decade. That is the disconfirming test passed.

Pressure-test 1 — is the pricing power durable or merely contractual? It is genuinely durable on the ~75% commercial book (the FAA qualification barrier is real and the customer base is fragmented and price-insensitive on small-dollar critical parts). It is more fragile on the defense book, where the counterparty is a single, sophisticated, politically-motivated buyer (the DoD) with the power to audit costs, demand refunds, and legislate sourcing. So the moat’s pricing latitude is asymmetric — wide and durable in commercial aftermarket, narrower and politically-contested in defense aftermarket.

Pressure-test 2 — the PMA/USM threat. Parts Manufacturer Approval (FAA-approved alternative parts) and Used Serviceable Material (refurbished teardown parts) are the structural attack on sole-source aftermarket pricing. HEICO is the dominant independent PMA player, having built a >$4B-revenue franchise undercutting OEM list prices ~30–50% where it can engineer a substitute. The threat is real but bounded: PMA is economically attractive only on high-volume, high-list-price parts (the engineering/certification spend has to pay back), so the long tail of low-volume TransDigm SKUs is uneconomic to copy; TransDigm’s deliberately fragmented catalog of thousands of low-volume parts is itself a defense. Management claims “no material share loss” from PMA/USM — credible but worth tracking, because the threat is secularly rising as HEICO scales, airlines push cost-down adoption, and the parked/retired fleet feeds USM supply.

The most thesis-relevant competitive development of the period: TransDigm bought into PMA. In January 2026 it agreed to acquire Jet Parts Engineering and Victor Sierra (~$2.2B, closed April 2026; ~$280M combined revenue) — proprietary PMA/aftermarket parts and repairs. This is both defensive (neutralizing a channel that could erode its own list pricing) and offensive (owning the substitute rather than being disintermediated by it). That the incumbent sole-source-pricing champion is paying ~7.9x revenue to own the PMA arbitrage is a quiet acknowledgment that the PMA threat is real enough to internalize.

Competitive set — the two “aerospace compounder twins.” TransDigm and HEICO are structural mirror-images:

They occasionally compete head-on (now more so, post-Jet Parts). TransDigm earns the fatter margin (sole-source pricing) but carries the political and leverage risk; HEICO earns less per part but is the secular share-gainer with a fortress balance sheet. Broader content competitors — RTX/Collins, Safran, Eaton, Parker (Meggitt), Curtiss-Wright, Woodward, Crane — are larger and lower-margin, relevant as design-in rivals but not as quality/valuation twins.

Verdict: durable, financially-proven moat — not a crowded market — but with asymmetric, contested edges. Greenwald-type intangibles (sole-source/FAA lock-in) plus switching costs, evidenced by 60% gross / 54% EBITDA margins on ~90% proprietary / ~80% sole-source sales. The moat is wide and durable in commercial aftermarket, narrower under DoD scrutiny in defense, and secularly pressured by PMA/USM — a pressure TransDigm just validated by spending $2.2B to internalize it. “No material share loss” is the open question to monitor, not a settled fact.

5. Growth History and Forward Opportunities

Historical growth has been a blend of cyclical recovery, organic pricing/volume, and relentless M&A. Revenue compounded as follows: FY2019 $5,223M → FY2020 $5,103M → FY2021 $4,798M (COVID trough) → FY2022 $5,429M → FY2023 $6,585M → FY2024 $7,940M → FY2025 $8,831M. That is a ~+84% rise off the trough in four years, roughly half organic (post-COVID traffic recovery plus pricing) and half acquired. EBITDA-As-Defined grew even faster — from ~$1.94B (FY2021) to $4.76B (FY2025) — because margins expanded ~1,340bps over the same span as aftermarket mix normalized and the operating playbook compounded.

The organic algorithm. In a normal year, TransDigm targets mid-single-digit-plus organic revenue growth from a combination of (i) above-inflation price increases on the proprietary/sole-source book, (ii) aftermarket volume tied to fleet utilization, and (iii) new-business “design-win” capture on emerging platforms. Q1-FY26 organic growth was 7.4%, with commercial OEM +17% (rebounding off the Boeing-strike-depressed prior year), commercial aftermarket +7%, and defense +7% (all pro forma). The honest blemish is that commercial-aftermarket growth has been lagging the broader market by ~5–6 percentage points — management attributes roughly half to under-exposure to engine content (the fastest-growing aftermarket slice) and half to distributor/airline inventory “lumpiness.” This is the single most-watched organic metric: bulls read the lag as transient destocking now reversing; bears read the engine-content under-exposure as a structural ceiling.

Forward opportunities. (1) Aftermarket re-acceleration — the Q2-FY26 guide lifted commercial-aftermarket growth to low-double-digits as destocking rolls off, the highest-conviction near-term driver. (2) OE ramp — rising 737 MAX and A320neo build rates feed TransDigm’s OE line now and seed aftermarket for decades. (3) Defense — a funded global re-armament cycle with TransDigm’s defense book >40% of revenue and growing. (4) M&A — the structural growth engine: ~$10B of acquisition firepower pro forma, deployed into proprietary aerospace targets at ~20% underwritten IRRs. (5) PMA expansion — the new Jet Parts/Victor Sierra platform adds a growth-above-market aftermarket channel.

The quality-of-growth question. Is the growth high- or low-quality? The organic growth is unambiguously high-quality — it is priced off a moat, throws off cash, and carries ~50%+ incremental margins. The acquired growth is high-quality only conditionally: it depends on continued availability of proprietary targets at prices that still pencil to a 20% IRR, and the platform is now large enough ($8.8B base) that maintaining the historical growth rate requires ever-larger or ever-more-numerous deals, in a market where TransDigm increasingly competes with PE for the same assets at full prices. The law of large numbers is the genuine forward constraint.

Verdict: high-quality growth, with a maturing acquisition engine. Organic growth is moat-priced and cash-generative; M&A growth has a multi-decade track record but faces a scale headwind and a richer deal environment. The mix is shifting gradually from “acquire-and-reprice” toward “compound the installed base,” which is lower-octane but higher-certainty.

6. Financial Quality

Margins and operating leverage. TransDigm’s margin structure is exceptional and improving: gross margin 60.1% (FY2025, up from 52.4% in FY2021); EBITDA-As-Defined margin 53.9% (up from 40.5%); GAAP operating margin 47.4%. Incremental operating margins run ~50–69%, the signature of pricing power flowing to the bottom line. The margin expansion is partly cyclical (aftermarket-mix recovery off COVID) and partly structural (the operating playbook), and it has continued even as dilutive acquisitions (~200bps of recent margin drag) and lower-margin OE mix have been absorbed.

Returns on capital. ROIC was 16.9% in FY2025, up steadily from ~9.7% (FY2021 trough) — a genuinely high return for a capital-light business, and rising. Return on capital was 17.9%. ROE is not meaningful because book equity is negative (−$9.7B) — an artifact of the leveraged-dividend model, not of poor economics; the relevant return metric is ROIC, and it is strong and improving. The business is barely capital-intensive: net fixed assets are only ~$1.6B against $8.8B of revenue, and capex runs under 2% of sales, so nearly all EBITDA converts toward distributable cash.

Cash flow. FY2025 operating cash flow was $2,038M; with minimal capex, free cash flow is essentially the same figure, and management guides FY2026 FCF to ~$2.4B (rising on EBITDA growth, partially offset by a higher interest bill from acquisition debt). Cash conversion is high but gated by the interest bill: of $4.76B EBITDA-As-Defined, ~$1.57B (FY2025) goes to interest — the cost of the leveraged model. EBITDA/interest coverage is ~3.1x, comfortably above the 2–3x target floor but a reminder that roughly a third of EBITDA is pre-committed to debt service.

Balance sheet — the defining feature. Gross debt is ~$30B; net debt ~$27.2B (FY2025), pro forma ~$29B after the Feb-2026 $2.0B note issuance and the Stellant/Jet Parts deals. Net leverage is ~5.7x EBITDA, deliberately within the 5–7x target band. ~75% of the debt is fixed-rate through FY2029 (via fixed notes plus swaps/caps/collars), so near-term rate risk is muted; the structure is covenant-light and long-dated, so near-term refinancing risk is low. Liquidity is ample (~$2.5–2.8B cash plus revolver availability). The negative book equity (−$9.7B) is an output of returning more than cumulative earnings to shareholders via special dividends, not a sign of distress — but it does mean P/B and P/TBV are meaningless for this name, and that the equity is a thin, highly-levered claim on a large, stable cash stream. A material, sustained downturn in aftermarket cash flow against a $30B fixed-charge stack is the scenario that matters.

Quality of earnings. Accounting is relatively clean: revenue is product shipments (no long-cycle percentage-of-completion games), cash conversion tracks net income (FY2025 OCF/NI ~0.98x, dampened by working-capital build on growth), and stock-based comp is modest (~$157M, ~1.8% of revenue) for a company of this size. The main normalization items are (i) acquisition-related amortization (a large non-cash charge — intangibles are $14B of the $22.9B balance sheet — which depresses GAAP EPS relative to cash earnings, the reason management and the Street use EBITDA-As-Defined and adjusted EPS) and (ii) the swings in “non-operating” items. There is no evidence of aggressive accounting; the Citron “Valeant” comparison (2017) was about aggressive price-driven accretion, not accounting fraud, and unlike Valeant the cash earnings have proven durable for nine subsequent years.

Verdict: economics improve with scale, decisively — but the equity is a leveraged claim. Margins, returns on capital, and cash conversion are all top-decile for industrials and have risen with size, confirming a real moat. The qualifier is entirely on the right-hand side of the balance sheet: this is a wonderful operating business financed as a high-yield leveraged-equity structure, and the financial-quality verdict on the operations (excellent) must be held alongside the financial-risk verdict on the capital structure (high, deliberate, and rate-/cycle-sensitive).

7. Capital Allocation

Capital allocation is TransDigm’s core competence and its defining identity — the model is built around it. The stated priority stack (reaffirmed Q1-FY26): (1) reinvest in the existing businesses; (2) accretive, disciplined M&A; (3) return capital via buybacks or dividends; (4) pay down debt (explicitly “unlikely”). The through-line is per-share intrinsic-value compounding, financed with leverage.

M&A — the engine. TransDigm is a serial acquirer of proprietary, sole-source, aftermarket-rich aerospace component makers, applying a “value-driver” playbook (price, productivity, new-business development) to underwrite ~20% IRRs. The track record spans the transformational (Esterline, 2019, ~$4B) to a steady cadence of bolt-ons (Cobham connectors, Calspan, CPI/Electron Device, Extant, Raptor Scientific, and others). The FY2025–26 cadence was unusually heavy: Simmonds Precision (~$765M from RTX, closed Oct-2025), Servotronics ($47/share ~$110M after a topping war that forced a 22% bid bump — itself a sign of competition for scarce sole-source assets), Stellant Systems (~$960M, announced Dec-2025), and Jet Parts Engineering + Victor Sierra (~$2.2B PMA, closed Apr-2026). Pro forma, management cites ~$10B of remaining acquisition firepower. The integration record is strong (decades of margin accretion); the open question is undisclosed entry multiples and whether the model’s ~20% IRRs survive a maturing platform competing with PE at full prices.

Capital returns — episodic special dividends, not steady buybacks. TransDigm returns capital in large, debt-funded special dividends timed opportunistically rather than a regular dividend: ~$22.85/share (2017), $30 (2020), $18.50 (2022), $35 (2023), and a record $75/share (Oct-2024) + $90/share (Sep-2025) = ~$9.6B in FY2025, plus $500M of buybacks (FY2025) and ~$100M more in Q1-FY26. Each special dividend strips equity out and re-levers the structure — the mechanical source of the negative book value — and is the reason the equity has compounded faster than the operating business. Buybacks are secondary and opportunistic (deployed into share-price dips). With ~$3.2B of fresh M&A absorbing capital, the next special dividend’s timing is the open capital-allocation question for FY2026.

Incentive alignment — genuinely returns-aware, which is rare. Management compensation is overwhelmingly long-vesting stock options that vest on AOP (Annual Operating Performance) per diluted share growth — full vesting at 17.5%/year (benchmarked to “high-performing private equity”), and zero vesting below 10%. This is a per-share, returns-based metric, not a revenue/scale-vanity target — exactly the structure a fundamental investor wants. The historical blemish was the magnitude of grants and a “dividend-equivalent” feature that adjusted option strikes downward for special dividends (keeping option holders whole on payouts they didn’t receive); that feature ended in 2025, a genuine governance improvement. Say-on-pay support recovered sharply (33.8% in 2022 → 68.8% in 2024 → 94.4% in 2025) after engagement and changes. FY2025 CEO (Stein) total pay was ~$25M; several Co-COOs were paid more on a total basis due to special-dividend-related option adjustments. Incoming CEO Lisman elected to take base salary and short-term incentives entirely in options — a notable alignment signal.

Insider behavior — no conviction buying. Across ~85 Form 4 filings (2024–2026), essentially all transactions are mechanical option-exercise-and-sell; there are exactly two code-P open-market purchases, both de minimis (Lisman’s $1.2M buy in Feb-2026; a 1-share director technicality). Founder/Chairman W. Nicholas Howley monetizes option tranches monthly, selling down to a retained floor. This is not a red flag (the comp structure is the alignment, and Howley retains a large position), but there is no insider-buying signal to lean on either.

Verdict: management has allocated capital intelligently — exceptionally so — within a deliberately risky structure. The combination of disciplined, returns-underwritten M&A; per-share-value-based incentives; and a leveraged-dividend equity structure has compounded shareholder value at an elite rate for two decades. The verdict is positive, with two standing caveats: the model’s returns face a scale headwind, and the leverage that amplifies the upside also amplifies the downside.

8. Changes and Headwinds — Last Two Years

Why the stock stalled while fundamentals grew. Over the trailing ~12 months TDG fell ~23% from its ~$1,624 peak to ~$1,256, materially lagging an Aerospace & Defense sector that rose sharply — despite FY2025 revenue +11% and EBITDA-As-Defined +14%. The de-rate is a multiple story, not an earnings story, driven by three reinforcing factors: (1) a commercial-aftermarket air-pocket — distributor/channel destocking that management flagged as a 1–2pt drag, compounded by low Boeing/Airbus build rates and the 2024 Boeing strike (Q3-FY25 commercial-OEM revenue fell ~7% and full-year guidance was trimmed ~$60M); (2) a richly-valued, ~5.7x-levered, rate-sensitive equity meeting higher-for-longer rates, which pressured both the discount rate and the floating-rate interest bill; and (3) sentiment/rotation plus a digested ~$90 special dividend that mechanically dropped the ex-date price and removed a near-term catalyst, alongside sell-side downgrades (Baird to Neutral, KeyBanc to Sector Weight).

The turn is now visible. Q1-FY26 (reported Feb-2026) beat and raised guidance. Q2-FY26 (reported May-2026) was the cleaner inflection: revenue +18.3% to $2.54B, adjusted EPS $9.85 (above consensus), FY2026 guidance raised (sales to $10.3–10.4B, adjusted EPS to $38.83–40.21), and — critically — the commercial-aftermarket growth guide lifted to low-double-digits as destocking rolled off. Shares popped on the print. So the “down ~23%” reflects the FY2025 destocking air-pocket; the aftermarket re-acceleration is the offsetting bull evidence.

CEO transition — smooth and telegraphed. Announced May-2025: Kevin Stein (CEO since 2018) retired effective Sep-30-2025; Mike Lisman (long-tenured CFO, then Co-COO) became President & CEO on Oct-1-2025, with Stein staying as advisor through Mar-2026 and remaining a director. The operating structure (Co-COOs Murphy and Reiss, CFO Wynne) and founder-Chairman Howley provide continuity. This is an internal, low-drama succession with explicit strategy continuity — not a thesis-changer.

M&A wave. ~$4B+ of on-strategy deals in 18 months (Simmonds, Servotronics, Stellant, Jet Parts/Victor Sierra), funded by cash plus the Feb-2026 $2.0B note issuance ($1.2B 6.125% sub notes due 2034 + an $800M term loan due 2033). The Servotronics topping war and the full ~7.9x-revenue PMA price signal a hot acquisition market.

Defense-pricing overhang — latent, not active. The DoD-Inspector-General “excess profit” saga ($16.1M refunded 2019; ~$21M flagged 2021) plus recurring congressional pricing letters remain a real but historical overhang; no major new 2024–2026 OIG finding surfaced in this review. With defense now >40% of revenue, it is a recurring headline/legislative risk (cost-data mandates, alternative-sourcing pushes) rather than a fresh catalyst. Tariff exposure (2025 regime) is plausibly modest given US-centric manufacturing and pricing power, but is a margin-timing risk to monitor.

Verdict: the changes are net thesis-confirming, after a scare. The FY2025 air-pocket was a genuine, fundamentals-light headwind that the market over-extrapolated into a 23% de-rate; the Q2-FY26 beat-and-raise, rising build rates, and smooth succession point to the air-pocket rolling off. The standing headwinds — leverage into a late cycle, latent defense politics, and a maturing M&A engine — are structural, not new.

9. Risk Analysis

Catastrophic-loss assessment. A total loss is remote — the underlying cash flows are diversified across thousands of sole-source parts, ~50 operating units, and three end markets, and the debt is long-dated and mostly fixed. The realistic severe-downside scenario is not bankruptcy but a compound hit: an aftermarket downturn (or a binding defense-pricing reform) that compresses cash flow and the multiple while the $30B debt stack magnifies the equity drawdown — the 2020 COVID episode (stock −60% peak-to-trough) is the template, and the company survived it intact and emerged stronger.

10. Valuation Discussion (Embedded Expectations)

Where the multiple sits. At $1,255.67 (June 12, 2026), TDG carries a market cap of ~$70.3B and an enterprise value of ~$99B (pro forma net debt ~$29B). On that basis:

The central valuation observation. TransDigm is the highest-margin business in the aerospace-compounder cohort yet trades at the lowest EV/EBITDA multiple in it, and at only the 64th percentile of its own ten-year range — a genuinely unusual setup for a franchise of this quality. The market’s discount is explicable: ~5.7x leverage (which inflates the P/E by depressing net income, so EV/EBITDA is the cleaner lens and on it TDG is cheapest), recurring defense-pricing headline risk, and the maturity/large-numbers question. Note P/B is meaningless here (negative equity) — value the name on EV/EBITDA, FCF yield, and earnings, never on book.

Embedded-expectations / reverse-DCF. At ~$99B EV against ~$5.4B forward EBITDA-As-Defined (~18.3x), the multiple embeds far less heroic growth than its cohort peers. A simple reverse-DCF: to justify today’s EV at a ~9% discount rate, TransDigm must compound enterprise free cash flow at roughly 8–11% per year for a decade — a rate below its historical compounding and well within reach given mid-single-digit-plus organic growth, continued margin durability, and even a modest M&A contribution. By contrast, the comparable reverse-DCF for Howmet required a ~13–18% decade-long FCF CAGR just to clear the same bar. In other words, the embedded expectation in TDG is demanding by absolute standards but modest by the standards of its own history and its peers — the market is underwriting roughly a continuation of organic compounding, not a flawless bull case.

Scenario analysis (illustrative, 2–3 year horizon; not a price target):

• Bear (~25–30% downside): A commercial-aftermarket relapse (destocking proves to be demand, not inventory) or a binding defense-pricing reform compresses growth to low-single-digits and the multiple de-rates toward ~14–15x EV/EBITDA as the leverage is repriced. EBITDA stalls near $5B; the equity, levered, falls disproportionately. The 2020 analog (−60%) is the tail, requiring a traffic shock.
• Base (roughly flat to +15%): Aftermarket re-accelerates to high-single/low-double-digits as guided, FY2026 EBITDA-As-Defined reaches ~$5.4B and FY2027 ~$6.0B, M&A adds a few points, and the multiple holds near ~18x. Per-share value compounds with EBITDA plus the de-levering optionality; total return tracks ~10–15%/yr — the “compounding does the work, multiple holds” path.
• Bull (~25–40% upside): Aftermarket inflects to low-double-digits durably, the OE ramp accelerates, a large accretive acquisition lands at a 20% IRR, and the market re-rates TDG part-way toward its cohort (toward ~22–24x EV/EBITDA) as the air-pocket fear fades and leverage trends toward the low-5s. EBITDA and multiple expand together — the asymmetry that the current cohort-low multiple makes possible.

The asymmetry, plainly. Unlike Howmet (where the bear case worked entirely through multiple compression from a 95th-percentile starting point), TDG starts at a cohort-low, mid-own-history multiple. That limits the valuation downside and leaves room for re-rating upside — the bear case here has to work through fundamentals (an aftermarket relapse or a pricing-reform shock) plus leverage, not through an obviously stretched multiple. That is a materially better starting setup than the cohort’s richer names.

No price target. No recommendation. The body’s task is to frame what the price implies; the Claude’s Take block is the only place a directional view is expressed.

11. Variant Perception

Consensus belief. The sell-side is constructive-but-cooled: roughly 16 Buy / 7 Hold / 0 Sell, an average target around $1,550–1,570, with several 2026 downgrades (Baird to Neutral, KeyBanc to Sector Weight) on the aftermarket deceleration and valuation. Consensus accepts the moat and the model and debates the rate of aftermarket growth and the durability of the premium multiple.

Strongest bull case. TransDigm is a proven, two-decade ~20%-per-share compounder with a financially-verified moat (60% gross margins on sole-source parts), now trading at the cheapest EV/EBITDA in its cohort and the 64th percentile of its own range after a fundamentals-intact destocking air-pocket that is already reversing (Q2-FY26 +18% revenue, aftermarket guide to low-double-digits, rising 737 MAX rates). You are buying an elite capital allocator, with ~$10B of M&A firepower and a returns-based incentive structure, at a discount to its own history and its peers — with both EBITDA growth and multiple re-rating as ways to win, and a ~3.4% FCF yield underpinning it.

Strongest bear case. This is a ~5.7x-levered, $30B-debt, negative-book-equity structure whose ~32x-earnings equity is a thin claim on a cash stream that just demonstrated (FY2025) how quickly aftermarket can air-pocket. The growth engine is maturing (an $8.8B base needs ever-larger deals in a hot, full-priced M&A market), the highest-growth aftermarket slice (engines) is where TDG is structurally under-exposed, the defense book (>40% of revenue) carries a recurring, bipartisan pricing-reform risk that could cap its best pricing latitude, and PMA/USM is a secularly rising threat the company just paid $2.2B to partly neutralize. In a risk-off or higher-rate regime, the leverage and the premium multiple compound to the downside.

The 3–5 assumptions that matter most:

1. Aftermarket durability — is the Q2-FY26 re-acceleration to low-double-digits real demand, or a destocking-rebound head-fake? (Falsifies the bull if growth relapses to low-single-digits over the next 2–3 quarters.)
2. Pricing-power durability under politics — does the defense book retain its pricing latitude, or does cost-data/sourcing legislation cap it? (Falsifies the bull on a binding DoD reform.)
3. M&A IRR sustainability — can a maturing $8.8B platform keep deploying ~$3–5B/yr into ~20%-IRR proprietary targets? (Falsifies the bull if deal returns visibly compress / multiples paid keep rising.)
4. Leverage tolerance — can the structure stay at 5–7x and de-lever opportunistically, or does a downturn force it? (Falsifies the bear if leverage trends to low-5s through the cycle.)
5. Multiple re-rating — does the market re-close the gap to the cohort as the air-pocket fades, or does the leverage/politics discount persist? (Determines whether the bull’s re-rating leg pays.)

The factor-positioning read (where consensus may be offsides). FactorsToday places TDG with a low beta (~0.83), positive alpha (+0.05), and meaningful Quality and Low-Volatility loadings — a high-quality, defensive compounder — but with its momentum signal cooled to zero (relative strength −6% over 12 months, ~17–23% below peak) while its long-run relative strength remains near the top of the universe. This is the empirical fingerprint of a good business that has gone sideways for a year, not a crowded momentum trade (the Howmet profile) and not a falling knife (no broken trend, positive alpha). The closest factor peer is Howmet (0.95 similarity) — the same franchise quality at roughly double the EV/EBITDA multiple. The variant-perception edge: consensus has de-rated TDG for a transient air-pocket and a leverage/politics discount, leaving a proven compounder at a cohort-low multiple precisely when its highest-margin revenue line is re-accelerating — an offside that pays through both earnings growth and partial re-rating if the aftermarket recovery holds.

12. Fact vs. Interpretation Table

13. Open Questions

1. Is the aftermarket re-acceleration durable? The Q2-FY26 low-double-digit guide must hold for two-plus quarters to confirm the destocking air-pocket is over rather than a one-quarter rebound. The ~5–6pt lag to the broader aftermarket (half structural engine under-exposure, half lumpiness) is the metric to watch.
2. What multiples is TransDigm actually paying for M&A? Entry EBITDA multiples are undisclosed; the ~7.9x-revenue Jet Parts/Victor Sierra price and the Servotronics topping war suggest a full market. Do the ~20% underwritten IRRs still hold?
3. Will FY2026 bring another special dividend, or does the ~$3.2B M&A wave absorb the capacity? The capital-allocation signal for the year is unresolved.
4. Has any new DoD-IG finding or cost-data legislation emerged? No fresh 2024–2026 finding surfaced, but with defense >40% of revenue this is the latent risk to monitor each quarter.
5. Where does net leverage trend? Toward the low-5s (de-levering optionality, a bull input) or held at the high end to fund deals/dividends?
6. What is the precise aftermarket share of EBITDA and the defense share of revenue? Management cites “~two-thirds” and “>40%”; the exact figures refine the cyclicality and political-risk assessment.

14. What Must Be True

For the bull case to be right (proven compounder at a cohort discount, re-rating ahead):

• Commercial aftermarket must sustain high-single/low-double-digit organic growth through FY2026–27 (not relapse to low-single-digits).
• The moat’s pricing power must remain intact on the commercial book and avoid a binding defense-pricing cap.
• M&A must keep clearing ~20% IRRs without a visible step-up in multiples paid, and leverage must stay within (ideally trend below) the 5–7x band.
• The market must at least partially re-close the cohort-multiple gap as the air-pocket fear fades.
• Falsification test: two consecutive quarters of commercial-aftermarket growth back below ~5%, or a binding DoD/Congressional cost-data regime that demonstrably caps sole-source defense pricing, or a leverage-forced capital action (equity raise / dividend cut). Any one breaks the bull.

For the bear case to be right (over-levered, maturing, politically-exposed at a premium absolute multiple):

• Aftermarket growth must stall (engine under-exposure proves a structural ceiling) and/or defense pricing must be capped by reform.
• The M&A engine must visibly decelerate or destroy value (returns compress at scale; a large deal disappoints).
• The leverage must turn from amplifier to liability in a downturn or higher-rate regime, forcing a de-rate of the ~32x-earnings equity.
• Falsification test: commercial aftermarket re-accelerating to durable low-double-digits with leverage trending to the low-5s and a large acquisition closing at a credible ~20% IRR — that combination would confirm the compounding machine is intact and the discount unwarranted, breaking the bear.

15. Source Appendix

See Appendix B below for the full, dated source list. Primary sources: TransDigm FY2025 Form 10-K (filed 2025-11-12) and the FY2021–2024 10-Ks; FY2026 Q1 (Feb-2026) and Q2 (May-2026) earnings releases and call transcripts; the 2026 DEF 14A proxy; acquisition and debt 8-Ks (2025–2026); ROIC.ai financial data; own-history valuation-percentile analysis; the FactorsToday factor model; DoD-Inspector-General reports (2019, 2021); and reputable financial media as cited inline.

APPENDIX A — Standard Diligence Questionnaire

TransDigm Group (NYSE: TDG) — Standard Diligence Questionnaire

Supplemental to the analysis above. Fact / Interpretation / Assumption labels applied where material.

General

What thoughtful questions have other investors asked about this company? The recurring, sophisticated questions are: (1) Is the value-based pricing model durable, or is it a regulatory time-bomb? — i.e., will the DoD/Congressional scrutiny that produced the 2019/2021 excess-profit refunds eventually cap sole-source pricing on the now->40%-of-revenue defense book (Fact: two DoD-IG reports; Interpretation: latent, not yet binding). (2) Can the M&A engine keep running at scale? — an $8.8B-revenue base needs ever-larger deals to move the needle, in a market where TDG now competes with PE and pays full prices (Servotronics topping war; ~7.9x-revenue PMA deal). (3) Is the commercial-aftermarket growth lag (5–6pts below market) structural or transient? (4) How safe is the negative-book-equity, ~5.7x-levered balance sheet in a downturn? (5) Does the PMA threat (HEICO) erode the sole-source aftermarket moat over time? — sharpened now that TDG itself bought into PMA.

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Interpretation: mid-cycle, tilted toward early-recovery. Commercial OE is mid-cycle and ramping (737 MAX/A320neo); commercial aftermarket is early in its cycle and just rebounding from a FY2025 destocking air-pocket; defense is structurally funded. Margins (53.9% EBITDA-As-Defined) are at record highs, which argues “high,” but volumes — especially aftermarket — have recovery runway, which argues “not peak.”

Driven by external environment or internal actions? Both. External: air-traffic recovery, build rates, defense budgets. Internal: the value-based operating playbook (pricing, productivity, new-business development) and serial M&A — the internal levers are unusually large for an industrial, which is why margins rose ~1,340bps in four years.

How stable are revenues? Fact: ~55% aftermarket + >40% defense makes the revenue base far more stable than the OE supply chain; the COVID trough (FY21 revenue −6% off FY20, vs OE peers down far more) demonstrated the resilience. The ~45% OE leg is the cyclical portion.

Outlook for products/services; how big is the market? Growing. Global commercial MRO ~$139B (2026) → ~$165B (2035), ~3.9% CAGR; air traffic +4–5%/yr; defense funded by a multi-decade global re-armament cycle. International is a meaningful and growing share (commercial fleets and NATO/allied defense).

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Interpretation: stable-to-slightly-more-competitive at the edges. The sole-source/FAA barrier keeps the core uncontested, but PMA/USM (HEICO-led) is a secularly rising challenge to aftermarket pricing, and the M&A market for proprietary assets is more competitive (PE bidding).

How profitable is the business (ROIC, ROE)? Fact: ROIC 16.9% (FY25), rising; return on capital 17.9%. ROE not meaningful (negative book equity by design). Gross margin 60.1%, EBITDA-As-Defined 53.9% — top-decile for industrials.

How profitable is the industry — competitors, barriers? The aftermarket profit pool is excellent; barriers (FAA qualification, sole-source design-in, decades-long platform lives) are high. Few competitors can replicate the proprietary-sole-source model at scale — HEICO (the PMA mirror-image) and HWM (engine airfoils) are the closest quality analogs.

Can the business be easily understood? Yes at the model level (own proprietary aftermarket-heavy parts, price up, acquire, lever, distribute), though the ~50-unit, thousands-of-SKU catalog and the leveraged-dividend capital structure add complexity.

Can it be undermined by foreign low-cost labor? Largely no — the moat is engineering IP + FAA certification + sole-source position, not low-cost manufacturing. Flight-critical certification, not labor cost, is the barrier.

Do brands matter? Not consumer brands; what matters is qualification status and reliability reputation with OEMs/airlines/DoD — a B2B analog to brand (switching away from a trusted sole-source supplier carries safety/dispatch risk).

Nature of competition; switching costs? Competition is for new design-ins (years-long), not for installed content. Switching costs on installed sole-source parts are very high (re-qualification cost/time/risk vastly exceeds the part’s price) — the core of the moat.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? Yes, in economic substance: the value of the sole-source positions and qualification status is carried partly as $14B of acquired intangibles/goodwill and partly not at all (the internally-developed pricing-power franchise). The economic asset (the recurring aftermarket annuity) far exceeds book.

Off-balance-sheet liabilities? Nothing unusual flagged; operating leases are modest. The dominant liability is the on-balance-sheet $30B debt. (Open Question: routine litigation/indemnities.)

How conservative is the accounting? Interpretation: reasonably conservative/clean. Revenue is product shipments (no long-cycle POC estimation), cash conversion ~tracks net income, SBC is modest (~1.8% of sales). The main non-GAAP bridge is acquisition amortization (large, non-cash) — standard for a serial acquirer. No accounting red flags; the 2017 “Valeant” comparison was about price-driven accretion, not accounting.

How CapEx-hungry? Very capital-light — capex <2% of sales, net PP&E ~$1.6B on $8.8B revenue. Nearly all EBITDA is available for debt service, M&A, and distributions.

Capital Allocation & Management

How much FCF, and how is it used? Fact: FY2025 OCF/FCF ~$2.04B; FY2026 guide ~$2.4B. Uses, in priority: reinvest → M&A → return capital (special dividends/buybacks) → (unlikely) debt paydown. FCF is gated by the ~$1.57B interest bill.

Significant acquisitions recently? Fact: Simmonds Precision (~$765M), Servotronics (~$110M), Stellant (~$960M), Jet Parts Engineering + Victor Sierra (~$2.2B) — ~$4B+ in 18 months; ~$10B firepower remaining pro forma.

Buying back shares? Opportunistically — $500M (FY25), ~$100M (Q1-FY26). Buybacks are secondary to special dividends and M&A.

Issuing large amounts of new shares to insiders? Options are the comp currency, but net dilution is modest (share count ~54–56M, roughly flat over five years); options vest only on per-share AOP growth (≥10% to vest at all, full at 17.5%).

Compensation policy / motivations of management? Fact: overwhelmingly long-vesting options gated on per-share operating performance — genuinely returns-aware. Say-on-pay recovered to 94.4% (2025) from 33.8% (2022); the dividend-equivalent option feature ended in 2025. CEO Lisman takes salary/STI entirely in options. Interpretation: alignment is strong; the historical concern was grant magnitude, now better-received.

Valuation & Market Data

ADR / MLP / K-1? No — ordinary US C-corp common stock (NYSE), 1099 not K-1.

Dividend policy? No regular dividend; episodic large special dividends (e.g., $75 + $90/share in FY2025 = ~$9.6B) funded by debt. Trailing yield optically ~7% reflects the special, not a recurring payout.

How profitable; net income vs. cash from operations? Very profitable (23.5% net margin, 16.9% ROIC). OCF/NI ~0.98x (FY25) — cash earnings track net income closely; the gap is working-capital build on growth, not a quality flag. Note GAAP EPS is understated vs cash earnings by large acquisition amortization.

Risks & Downside

What would cause the stock to decline? A commercial-aftermarket relapse; a binding defense-pricing reform; a higher-for-longer/risk-off regime repricing the leverage; a large M&A misstep; a Boeing/Airbus rate cut; a broad air-traffic shock.

Risk of catastrophic loss? Low-to-moderate and compound in nature: not bankruptcy (diversified cash flows, long-dated mostly-fixed debt) but a severe equity drawdown if an aftermarket downturn (or pricing-reform shock) compresses cash flow and the multiple against a $30B fixed-charge stack — the 2020 template (−60% peak-to-trough, fully recovered).

Chance of a total loss? Remote. Diversification across ~50 units, thousands of sole-source SKUs, and three end markets, plus a covenant-light/long-dated debt structure, make a wipeout highly unlikely absent an extreme, sustained traffic collapse.

Recent News & Events

Has the business environment changed recently? Yes, favorably after a scare: the FY2025 commercial-aftermarket destocking air-pocket drove a ~23% de-rate; Q2-FY26 (May-2026) delivered a beat-and-raise (+18% revenue, aftermarket guide lifted to low-double-digits) as destocking rolled off and 737 MAX rates climbed.

Significant acquisitions / accounting changes / new markets? ~$4B+ of M&A (incl. the first major PMA platform — Jet Parts/Victor Sierra); a Feb-2026 $2.0B debt issuance to fund deals; no material accounting-policy changes. CEO transition (Mike Lisman, Oct-2025) with explicit strategy continuity.

APPENDIX B — Source Appendix

TransDigm Group (NYSE: TDG) — Source Appendix

Primary sources prioritized. Accessed 2026-06-14 unless noted. Third-party data labeled where used.

Primary — SEC Filings (EDGAR, CIK 0001260221)

• Form 10-K, FY2025 (filed 2025-11-12, period ended 2025-09-30) — segment data, ~90% proprietary / ~55% aftermarket disclosure, debt structure, risk factors.
• Forms 10-K, FY2021–FY2024 — multi-year revenue/margin/leverage history.
• Form 10-Q, Q1-FY2026 (period ended ~2025-12-27) and Q2-FY2026 (period ended ~2026-03-28) — quarterly trends, buybacks, leverage.
• DEF 14A proxy, 2026 (filed 2026-01-23) — compensation (AOP-per-share vesting; full vest 17.5%, zero <10%), say-on-pay 94.4% (2025), director/insider ownership, dividend-equivalent feature ended 2025.
• Form 8-Ks (2024–2026): special-dividend declarations ($75/share Oct-2024; $90/share Sep-2025); CEO transition (Lisman effective 2025-10-01); acquisition announcements (Simmonds, Servotronics, Stellant, Jet Parts/Victor Sierra); $2.0B debt issuance (2026-02-10, 6.125% sub notes due 2034 + term loan due 2033).
• Form 4 corpus (2024–2026) — insider transactions; ~85 filings, almost all option-exercise-and-sell; two de-minimis code-P buys.

Primary — Earnings Calls & Releases

• TransDigm FY2026 Q1 earnings call transcript (2026-02-03) — strategy reiteration, FY26 initial guide ($9.94B sales / $5.21B EBITDA / $38.38 adj EPS), aftermarket 5–6pt lag commentary, M&A update (Stellant, Jet Parts/Victor Sierra), ~$10B firepower, leverage 5.7x.
• TransDigm FY2026 Q2 earnings release & call (2026-05-05) — beat-and-raise: revenue +18.3% to $2.54B, adj EPS $9.85, FY26 guide raised to $10.3–10.4B sales / $38.83–40.21 adj EPS, aftermarket guide to low-double-digits.
• TransDigm FY2025 Q4 earnings release (Nov-2025) — FY25 EBITDA-As-Defined $4,760M (53.9%).

Quantitative Data Providers

• ROIC.ai (third-party financial data) — income statement, balance sheet, cash flow, profitability ratios (ROIC 16.9%), enterprise value (~$104B FY25), valuation multiples, per-share data. Third-party aggregated; reconciled to filings.
• Own-history valuation-percentile analysis (10-year multiple range, as of 2026-06-12) — composite 64.7th percentile, P/E 52.0th, P/S 77.4th; P/B not meaningful (negative book equity).
• FactorsToday (/stock-loadings, /stock-info, /related-stocks, accessed 2026-06-14) — beta ~0.83, alpha +0.05, Quality +0.156 / LowVol +0.132 loadings, momentum cooled; relative strength −6% 12m, ~17–23% below peak; closest factor peer HWM (0.95 similarity).
• Market price data — $1,255.67 close (2026-06-12).

Industry, Peer & Macro Sources

• Oliver Wyman, Global Fleet & MRO Market Forecast 2025–2035 — commercial MRO ~$139B (2026) → ~$165B (2035), ~3.9% CAGR.
• IATA 2026 outlook / monthly traffic releases — 2026 RPK ~+4–5%, record ~5.2B passengers.
• Boeing / Airbus production-rate reporting (2026) — 737 MAX ramping toward ~47/month; A320neo ~50–55/month toward 75 by ~2027.
• NATO Hague summit (2025) — 5%-of-GDP defense commitment by 2035; US FY2026 defense appropriation ~$895B.
• Peer valuation cross-checks — HEICO (HEI), Howmet (HWM), Curtiss-Wright (CW), Woodward (WWD), GE Aerospace (GE): EV/EBITDA and P/E from public market-data aggregators (gurufocus, stockanalysis, valueinvesting.io).

Governance / Controversy Sources

• DoD Inspector General reports — Feb–May 2019 (excess profit $16.1M, refunded) and Dec 2021 (~$21M flagged); House Oversight hearing (May 2019).
• Citron Research (Jan/Mar 2017) — “the Valeant of the aerospace industry” short thesis (CNBC coverage 2017-01-20).
• Reputable financial media — Reuters, CNBC, Defense News, GovExec, MarketBeat, StockAnalysis, Investing.com, Motley Fool/StockTitan transcripts, PR Newswire press releases (acquisitions, dividends, CEO transition) — as cited inline.

Note: news flow in the period was quiet for a large, clean filer; the recent-events timeline is built from primary filings/releases and trade press.